NCT07044427
- Conditions
- Balance Training Effects, Blood Protein Disorders, Cardiovascular Diseases, +15 more
- Locations
-
- University Hospital Heidelberg Heidelberg, Baden Würtemberg, Germany
Clinical trial condition
Lymphoproliferative Disorders
Explore clinical trials studying Lymphoproliferative Disorders. Study availability and eligibility vary by location and protocol.
10,146 public trials
2,034 recruiting studies
Lymphoproliferative Disorders trial results
NCT06357754
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Chronic Lymphocytic Leukaemia, +20 more
- Locations
-
- Local Institution - 0016 Portland, Oregon, United States
- Ut Southwestern Dallas, Texas, United States
- Huntsman Cancer Institute at the University of Utah Salt Lake City, Utah, United States
- Local Institution - 0004 Madison, Wisconsin, United States
Recruiting
VCRC Tissue Repository
NCT02967068
- Conditions
- Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis, Aortic Arch Syndromes, Aortic Diseases, +48 more
- Locations
-
- Brigham and Women's Hospital Boston, Massachusetts, United States
- Boston University School of Medicine Boston, Massachusetts, United States
- Cleveland Clinic Cleveland, Ohio, United States
- University of Pennsylvania Philadelphia, Pennsylvania, United States
NCT03004326
- Conditions
- Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis, Arteritis, Autoimmune Diseases, +46 more
- Locations
-
- University of California, Los Angeles Los Angeles, California, United States
- Boston University School of Medicine Boston, Massachusetts, United States
- Mayo Clinic Rochester, Minnesota, United States
- Cleveland Clinic Cleveland, Ohio, United States
NCT07361029
- Conditions
- Hematologic Diseases, Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
- Locations
-
- King Faisal Specialist Hospital and Research Center Riyadh, Riyadh Region, Saudi Arabia
NCT05706766
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
- Locations
-
- Dana Farber Cancer Institute Boston, Massachusetts, United States
- Dana-Farber Cancer Institute Boston, Massachusetts, United States
Recruiting
Anti CD19 Gene Therapy for B-cell Lymphoma
NCT07211048
- Conditions
- B-cell Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +8 more
- Locations
-
- Anhui Provincial Hospital Hefei, Anhui, China
Recruiting
Avo In R/R And Previously Untreated MCL
NCT04855695
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +9 more
- Locations
-
- University of Chicago Medical Center Chicago, Illinois, United States
- Beth Israel Deaconess Medical Center Boston, Massachusetts, United States
- Dana-Farber Cancer Institute Boston, Massachusetts, United States
NCT06889168
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +10 more
- Locations
-
- Columbia University Irving Medical Center New York, United States
- Medical University of South Carolina Charleston, South Carolina, United States
Recruiting
Relmacabtagene Autoleucel Combined With Sintilimab for Relapsed/Refractory B-cell Lymphoma
NCT07077512
- Conditions
- Follicular Lymphoma ( FL), Hemic and Lymphatic Diseases, Immune System Diseases, +13 more
- Locations
-
- Sun Yat-sen Universitiy Cancer Center Guangzhou, China
- Fifth Affiliated Hospital of Guangzhou Medical University Guangzhou, China
- Guangzhou overseas Chinese hospital Guangzhou, China